4 Results for "

rhEPO

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "rhEPO" in MCE Product Catalog:

Cat. No.: HY-114134
CAS No.: 122312-54-3
Purity:  ≥95.0%
Synonyms: rhEPO; EPOCH; Genetical recombination

Target:  

Inhibitory Antibodies

Research Areas:  

Metabolic Disease Cancer

Epoetin beta (rhEPO) is a recombinant form of erythropoietin. Epoetin beta is responsible for the maintenance of erythropoiesis and can be used for anaemia research .
loading...
    loading...
Cat. No.: HY-174428
Target:  

PROTACs JAK STAT Apoptosis

Research Areas:  

Cancer

PROTAC JAK2 degrader-1 is a JAK2 PROTAC degrader, with a DC50 of 27.35 nM. PROTAC JAK2 degrader-1 induces JAK2 degradation via the ubiquitin-proteasome pathway. PROTAC JAK2 degrader-1 inhibits the JAK2-STAT signaling pathway. PROTAC JAK2 degrader-1 induces G2/M phase arrest and apoptosis in cancer cells. PROTAC JAK2 degrader-1 exhibits antiproliferative activity against cancer cells. PROTAC JAK2 degrader-1 inhibits recombinant human erythropoietin (rhEPO)-mediated polycythemia and splenomegaly in mice. PROTAC JAK2 degrader-1 can be used for research on myeloproliferative neoplasms, including polycythemia vera .
loading...
    loading...
Cat. No.: HY-174988
Target:  

JAK STAT

Research Areas:  

Cancer

JAK2-IN-13 is a potent and orally active JAK2 inhibitor with an IC50 of 54.7 nM. JAK2-IN-13 downregulates the expressions of p-STAT3 and p-STAT5. JAK2-IN-13 exhibits good bioavailability and potent inhibition of rhEPO-induced extramedullary erythropoiesis and polycythemia vera. JAK2-IN-13 can be used for the study of myeloproliferative neoplasms .
loading...
    loading...
Cat. No.: HY-178936
CAS No.: 3094174-82-7
Target:  

JAK STAT

Research Areas:  

Inflammation/Immunology Cancer

JAK2-IN-15 is an orally active, potent, selective JAK2 inhibitor (IC50 = 1.17 nM). JAK2-IN-15 can inhibit the AK2-STAT signaling pathway. JAK2-IN-15 significantly improves key pathological indicators such as hematocrit and splenomegaly in an Epoetin beta (HY-114134) (rhEPO)-induced mouse model. JAK2-IN-15 can be used for the study of Polycythemia Vera (PV) .
loading...
    loading...